Author:
Fischer T,Reifenrath C,Hess GR,Corsetti MT,Kreil S,Beck J,Meinhardt P,Beltrami G,Schuch B,Gschaidmeier H,Hehlmann R,Hochhaus A,Carella A,Huber C
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference33 articles.
1. Goldman JM, Druker BJ . Chronic myeloid leukemia: current treatment options Blood 2001 98: 2039–2042
2. Silver RT, Woolf SH, Hehlmann R, Appelbaum FR, Anderson J, Bennett C, Goldman JM, Guilhot F, Kantarjian HM, Lichtin AE, Talpaz M, Tura S . An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemias: developed for the American Society of Hematology Blood 1999 94: 1517–1536
3. Hehlmann R, Hochhaus A, Berger U, Reiter A . Current trends in the management of chronic myelogenous leukemia Ann Hematol 2000 79: 345–354
4. Italian Cooperative Study Group on CML. IFN-alpha2a as compared with conventional chemotherapy for the treatment of CML N Engl J Med 1994 330: 820–825
5. Chronic Myeloid Leukemia Triallists’ Collaborative Group. Interferon alpha versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials J Natl Cancer Inst 1997 89: 1616–1620
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献